share_log

Redhill Biopharma | SCHEDULE 13D: Others

SEC ·  Aug 7 16:51

Summary by Moomoo AI

On March 22, 2024, a significant filing was made with the Securities and Exchange Commission by Quintairos, Prieto, Wood & Boyer P.A. on behalf of Avi Polischuk, Regina Polischuk, and R&S United Services regarding their holdings in RedHill Biopharma Ltd. The Schedule 13D filing indicates that Avi Polischuk, Regina Polischuk, and R&S United Services collectively hold a 15.12% interest in the company. Avi Polischuk personally holds 1,325,000 shares, Regina Polischuk owns 160,000 shares, and R&S United Services holds 1,875,590 shares of RedHill Biopharma's ordinary shares. The address of the principal executive offices of RedHill Biopharma Ltd. is listed as 21 Ha'Arba'a Street, Tel Aviv, Israel. The filing, signed by Anthony Varbero on August 7, 2024, confirms the accuracy and completeness of the information to the best of the signatory's knowledge.
On March 22, 2024, a significant filing was made with the Securities and Exchange Commission by Quintairos, Prieto, Wood & Boyer P.A. on behalf of Avi Polischuk, Regina Polischuk, and R&S United Services regarding their holdings in RedHill Biopharma Ltd. The Schedule 13D filing indicates that Avi Polischuk, Regina Polischuk, and R&S United Services collectively hold a 15.12% interest in the company. Avi Polischuk personally holds 1,325,000 shares, Regina Polischuk owns 160,000 shares, and R&S United Services holds 1,875,590 shares of RedHill Biopharma's ordinary shares. The address of the principal executive offices of RedHill Biopharma Ltd. is listed as 21 Ha'Arba'a Street, Tel Aviv, Israel. The filing, signed by Anthony Varbero on August 7, 2024, confirms the accuracy and completeness of the information to the best of the signatory's knowledge.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more